Gamithromycin Isomer Impurity
● Under Development
| Catalogue No.: | VE0010082 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C40H76N2O12 |
| Mol. Weight: | 777.04 g/mol |
Additional information on Gamithromycin Isomer Impurity
Parent drug
GamithromycinIUPAC Name
Gamithromycin Isomer impuritySynonyms
(3R,6R,8R,9R,10S,11S,12R)-2-((2R,3S)-2,3-dihydroxypentan-2-yl)-9-(((2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-hydroxy-11-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,6,8,10,12-pentamethyl-5-propyl-1-oxa-5-azacyclotridecan-13-one;Description
It is one of impurity present in Gamithromycin, Gamithromycin is approved for the treatment and prevention of bovine respiratory disease, which is caused mainly by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma species. Gamithromycin is an antibiotic used in cattle.References
Yang, Q., Liu, X., Zhang, C., Yong, K., Clifton, A. C., Ding, H., & Liu, Y. (2019). Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01090Request a Quote
« * » indique les champs nécessaires
